Selventa and Rosa in early-stage drug discovery deal
March 2011
SHARING OPTIONS:

CAMBRIDGE, Mass.—Selventa, which evolved from Genstruct Inc., has formed a strategic scientific alliance with Rosa and Co., a drug development advisory firm with expertise in drug-disease modeling and simulation. According to the companies, the alliance will bring together established analytical capabilities of both companies to better inform drug discovery and development decisions. The new partnership will provide access to a combination of knowledge assets, proprietary data, physiologic model libraries and expertise in disease areas such as oncology, immunology, respiratory, inflammatory and metabolic diseases. Additional details were not released.


Back
 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.